Cat Metacam Dosage Calculator

How to Use the Cat Metacam Dosage Calculator

Using this cat Metacam dosage calculator is straightforward and designed to help both veterinary professionals and cat owners quickly determine the appropriate meloxicam dose. To begin, enter your cat's body weight in the first field. You can choose between kilograms and pounds using the weight unit dropdown; the calculator will automatically convert pounds to kilograms behind the scenes for accurate dosing. Next, select the clinical indication from the dropdown. The three options correspond to the most common reasons Metacam is prescribed for cats: post-operative pain management, acute musculoskeletal disorders, and chronic musculoskeletal conditions such as osteoarthritis.

After selecting the indication, choose the treatment phase. The initial dose, given within the first 24 hours, is typically higher than the maintenance dose used on subsequent days. Finally, pick the formulation your veterinarian has prescribed. The calculator supports both the 0.5 mg/mL oral suspension and the 2 mg/mL injectable solution. Once all fields are filled, click the "Calculate Dosage" button. The results display both the initial and maintenance doses simultaneously, showing the dose in milligrams and the corresponding volume in milliliters for your selected formulation. This dual display lets you and your veterinarian plan ahead for the full treatment course without needing to recalculate.

The calculator also includes a reference table for common cat weights ranging from 2 to 8 kg, covering post-operative and chronic musculoskeletal scenarios. If the weight you enter seems unusually high or low for a domestic cat, a warning will appear prompting you to double-check the value. Remember that this tool is for informational and educational purposes. It should never replace professional veterinary advice.

What Is Metacam (Meloxicam)?

Metacam is the veterinary brand name for meloxicam, a non-steroidal anti-inflammatory drug (NSAID) manufactured by Boehringer Ingelheim. Meloxicam belongs to the oxicam class of NSAIDs and works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a central role in the production of prostaglandins responsible for inflammation, pain, and fever. By reducing prostaglandin synthesis at the site of injury or disease, Metacam provides analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effects.

In veterinary medicine, meloxicam has been widely used in dogs for many years and is available in multiple formulations including oral suspensions, injectable solutions, and chewable tablets. For cats, however, the pharmacology is notably different. Cats metabolize meloxicam much more slowly than dogs, which means the drug stays in their system significantly longer. This extended half-life has important implications for dosing frequency and safety, particularly when it comes to repeated or long-term administration.

The feline-specific Metacam oral suspension is formulated at a concentration of 0.5 mg/mL, which is deliberately lower than the canine version (1.5 mg/mL) to reduce the risk of accidental overdose. The injectable formulation for cats is 2 mg/mL and is typically administered subcutaneously by a veterinarian. It is critically important that only veterinary meloxicam formulations labeled for cats are used. Human meloxicam tablets, which come in 7.5 mg and 15 mg strengths, are far too concentrated and can be lethal even in small fractions of a tablet.

When Is Metacam Prescribed for Cats?

Veterinarians prescribe Metacam for cats in several clinical scenarios, each with specific dosing protocols and duration considerations. Understanding why your vet has chosen this medication helps you appreciate the importance of following the prescribed dose exactly.

Post-surgical pain management is one of the most common uses. After procedures such as spaying, neutering, dental extractions, or orthopedic surgery, cats experience acute pain and inflammation. A single subcutaneous injection of Metacam at 0.2 mg/kg is typically administered before or immediately after surgery, while the cat is still under veterinary supervision. In some countries, a follow-up oral dose of 0.05 mg/kg may be given the next day, but in the United States, only the single injection is FDA-approved for cats.

Acute musculoskeletal pain arising from injuries such as sprains, strains, or trauma may also be treated with Metacam. The initial dose is 0.2 mg/kg, followed by 0.05 mg/kg daily for a limited number of days as determined by the veterinarian. This short-course treatment aims to control inflammation and pain during the critical healing window.

Chronic musculoskeletal conditions, most notably osteoarthritis (degenerative joint disease), represent a more complex therapeutic challenge in cats. Osteoarthritis affects a significant proportion of older cats, with some studies suggesting up to 90% of cats over 12 years old show radiographic evidence of joint disease. In countries where long-term oral meloxicam use in cats is approved (such as the European Union, Australia, and Canada), the initial dose for chronic conditions is typically 0.1 mg/kg on the first day, followed by a maintenance dose of 0.05 mg/kg once daily. The treatment duration can extend for weeks or even months under careful veterinary monitoring, with regular blood tests to check kidney and liver function. However, in the United States, the FDA has not approved Metacam for repeated use in cats, and a black box warning specifically cautions against it.

Cat Metacam Dosage Chart

The following detailed dosage chart covers all three indications and both treatment phases. All doses are calculated per kilogram of body weight and should be adjusted to your cat's exact weight. The volume shown assumes the 0.5 mg/mL oral suspension unless otherwise noted.

It is essential to note that the lowest effective dose should always be used for the shortest possible duration. Cats receiving maintenance doses for more than a few days must have regular veterinary check-ups including blood work to monitor renal and hepatic function.

Available Formulations Explained

Metacam for cats comes in two primary formulations, each designed for specific clinical situations. Understanding the differences between them is crucial for safe and effective administration.

Oral suspension (0.5 mg/mL): This is the most commonly dispensed formulation for at-home use. It comes as a honey-colored liquid in a bottle with a calibrated dosing syringe. The 0.5 mg/mL concentration is specifically designed for cats; the canine oral suspension is 1.5 mg/mL and must never be substituted, as doing so triples the intended dose and can cause severe toxicity. The feline oral suspension is typically prescribed for maintenance dosing after the initial injection at the veterinary clinic. Each bottle includes a syringe marked in both milligrams and body weight increments to minimize dosing errors. The suspension has a palatable flavor that most cats accept when mixed with a small amount of food or administered directly into the mouth.

Injectable solution (2 mg/mL): The injectable form is used primarily in veterinary clinics and hospitals. It is administered as a subcutaneous (SC) injection, typically in the scruff of the neck. This formulation is used for the initial dose in post-operative settings or when rapid onset of pain relief is required. Because the concentration is four times higher than the oral suspension, even small volume errors can result in significant overdosing. For this reason, injectable Metacam should only be administered by trained veterinary personnel using precision syringes. A 5 mg/mL injectable formulation also exists and is intended for dogs; it must never be used in cats due to the extreme risk of overdose.

How to Administer Metacam to Cats

Proper administration of Metacam to cats requires attention to detail and a gentle approach. Here are step-by-step guidelines for the oral suspension, which is the formulation most commonly given at home.

Step 1: Prepare the dose. Shake the bottle gently before use. Draw up the prescribed volume using the calibrated syringe provided with the medication. Double-check the amount against your veterinarian's instructions. The syringe should be read at the top of the plunger line. Do not use kitchen teaspoons or tablespoons, as these are inaccurate for medication dosing.

Step 2: Choose your method. You have two main options for getting the medication into your cat. The first is to mix it with a small amount of food. Place the Metacam on top of a small portion of wet food (about a tablespoon) and ensure your cat eats all of it before offering the rest of the meal. This method works best with cats that are reliable eaters. The second option is direct oral administration. Gently restrain your cat, tilt the head slightly upward, insert the syringe tip into the side of the mouth between the cheek and teeth, and slowly depress the plunger. Allow the cat to swallow naturally.

Step 3: Give with food. Metacam should be administered with food or shortly after eating to reduce the risk of gastrointestinal irritation. Giving NSAIDs on an empty stomach increases the likelihood of vomiting, stomach ulcers, and other GI side effects. If your cat refuses to eat, contact your veterinarian before administering the medication.

Step 4: Timing and consistency. Administer Metacam at approximately the same time each day. Consistent timing helps maintain steady drug levels in the bloodstream and provides the most effective pain relief. If you miss a dose, give it as soon as you remember, but if it is close to the next scheduled dose, skip the missed one. Never give a double dose to compensate.

Step 5: Storage and hygiene. Store the oral suspension at room temperature, away from direct sunlight. Replace the cap firmly after each use. Clean the dosing syringe with warm water after each use and allow it to dry. Do not use soap or detergent inside the syringe. Discard any unused medication after the expiry date or six months after first opening, whichever comes first.

Pharmacokinetics: Half-Life and Clearance

Understanding how Metacam moves through a cat's body is essential for safe prescribing and dosing. Pharmacokinetics describes how a drug is absorbed, distributed, metabolized, and eliminated.

After subcutaneous injection, meloxicam is rapidly absorbed with peak plasma concentrations reached within approximately 1.5 to 3 hours. Oral administration also results in good bioavailability, with peak levels typically occurring within 3 to 5 hours. The drug is highly protein-bound (approximately 97%) and distributes well into inflamed tissues, where it exerts its therapeutic effects.

The most clinically significant pharmacokinetic parameter in cats is the elimination half-life. In cats, meloxicam has a half-life of approximately 24 hours, which is considerably longer than in dogs (where the half-life is about 12 to 36 hours depending on the study) and much longer than in humans (approximately 20 hours). This extended half-life means that with daily dosing, meloxicam accumulates in the cat's body over several days before reaching steady-state concentrations.

It takes approximately five to six half-lives for a drug to be essentially eliminated from the body. For cats, this means it takes 6 or more days for meloxicam to fully clear the system after the last dose. This prolonged presence has important implications: if adverse effects develop, they may persist for nearly a week after discontinuation. It also means that switching to another NSAID or corticosteroid requires a washout period of at least one week to avoid drug interactions and additive toxicity.

Meloxicam is metabolized primarily by the liver through oxidation reactions and is excreted in both urine and feces. Cats with compromised hepatic or renal function may metabolize and excrete the drug even more slowly, further increasing the risk of accumulation and toxicity.

Side Effects of Metacam in Cats

While Metacam is generally well-tolerated when used according to the prescribed dose and duration, all medications carry the risk of side effects. In clinical trials and post-marketing surveillance, adverse effects in cats treated with meloxicam are reported at a frequency of less than 1 in 10,000 treated animals. However, the severity of potential adverse effects warrants careful monitoring.

Gastrointestinal effects are the most commonly reported side effects. These include decreased appetite or complete anorexia, vomiting (which may sometimes contain blood), diarrhea (which may be soft, watery, or contain blood or dark tarry material), and abdominal discomfort. Gastrointestinal ulceration is a serious potential complication that can occur even at recommended doses, particularly with prolonged use. Signs of GI ulceration include black tarry stools, vomiting blood, weakness, and pale gums.

Renal effects are of particular concern in cats. Meloxicam, like all NSAIDs, can reduce blood flow to the kidneys by inhibiting prostaglandin-mediated vasodilation of the afferent renal arteriole. In healthy, well-hydrated cats, this effect is usually clinically insignificant. However, in cats that are dehydrated, hypovolemic (low blood volume), or have pre-existing kidney disease, even a single dose of meloxicam can precipitate acute renal failure. Signs of kidney problems include increased thirst and urination, decreased urine output, lethargy, loss of appetite, vomiting, and swelling of the limbs or face.

Hepatic effects include elevation of liver enzymes (ALT, AST, ALP), which may indicate liver cell damage. In rare cases, clinical hepatitis or liver failure can develop. Regular monitoring of liver values is recommended for cats on extended meloxicam therapy.

Other reported side effects include lethargy and decreased activity, changes in behavior, skin reactions or allergic responses such as facial swelling, hives, or itching, and in extremely rare cases, anaphylaxis. If you observe any unusual symptoms in your cat after administering Metacam, discontinue the medication immediately and contact your veterinarian.

Contraindications

Metacam should not be used in certain cats due to significantly increased risks of serious adverse effects. The following are recognized contraindications for meloxicam use in cats:

• Kittens under 6 weeks of age: The immature liver and kidneys of very young kittens cannot adequately metabolize and excrete meloxicam, leading to a high risk of toxicity.
• Pregnant or nursing cats: NSAIDs can cross the placenta and are excreted in milk. They may cause premature closure of the ductus arteriosus in fetuses and adverse effects in nursing kittens.
• Cats with kidney disease: Pre-existing renal impairment of any degree significantly increases the risk of acute renal failure when NSAIDs are administered. This includes cats with chronic kidney disease (CKD) at any IRIS stage.
• Cats with liver disease: Hepatic impairment reduces the metabolism of meloxicam, leading to drug accumulation and increased risk of toxicity.
• Cats with gastrointestinal disorders: Active GI ulceration, bleeding, or inflammatory bowel disease are absolute contraindications due to the risk of worsening these conditions.
• Dehydrated or hypovolemic cats: These cats depend on prostaglandin-mediated renal blood flow to maintain kidney function. Blocking prostaglandin production with an NSAID can cause acute kidney injury.
• Cats with low blood pressure (hypotension): Similar to dehydration, hypotension compromises renal perfusion, making NSAID use dangerous.
• Cats receiving other NSAIDs or corticosteroids: Concurrent use of multiple anti-inflammatory drugs dramatically increases the risk of GI ulceration and renal damage. A washout period of at least 7 days is required when switching between these drug classes.
• Known hypersensitivity: Cats that have previously shown allergic reactions to meloxicam or any other NSAID should not receive Metacam.

Metacam Is NOT Safe for Long-Term Use in Cats in Some Countries

The situation is different in other countries. In the European Union, Australia, New Zealand, and Canada, the oral suspension of Metacam is licensed for longer-term use in cats for the treatment of chronic musculoskeletal disorders, including osteoarthritis. In these regions, the approved protocol involves a 0.1 mg/kg oral dose on the first day, followed by 0.05 mg/kg once daily, with the duration determined by the treating veterinarian based on clinical response and regular monitoring of blood parameters.

This international discrepancy in regulatory approval stems from differences in how regulatory agencies weigh the available evidence. The European Medicines Agency (EMA) and equivalent bodies in other countries have determined that the benefits of controlled, long-term, low-dose meloxicam therapy outweigh the risks for cats with chronic pain conditions, provided appropriate patient selection and monitoring protocols are followed. The FDA, on the other hand, has taken a more conservative stance based on adverse event reports and the challenges of ensuring owner compliance with monitoring requirements.

Regardless of where you live, the key takeaway is clear: never give your cat Metacam without veterinary supervision, never exceed the prescribed dose, and ensure your cat receives regular health check-ups including blood work if treatment extends beyond a single dose.

Can Cats Take Human Meloxicam?

Human meloxicam tablets are available in 7.5 mg and 15 mg strengths. To put this in perspective, a 4 kg cat's entire daily maintenance dose of Metacam is just 0.2 mg. A single human 7.5 mg tablet contains 37.5 times the daily maintenance dose for a 4 kg cat. Even a quarter of a human tablet (approximately 1.875 mg) would deliver more than nine times the appropriate dose. Such massive overdoses can cause acute kidney failure, gastrointestinal hemorrhage, liver failure, and death, often within 24 to 72 hours.

Human liquid meloxicam formulations, where available, are also inappropriate because they are formulated at different concentrations than the veterinary product and lack the calibrated dosing syringe designed for feline body weights. Additionally, some human formulations contain excipients (inactive ingredients) that may be toxic to cats, including certain sweeteners and preservatives.

If your cat is in pain and you do not have access to veterinary Metacam, do not attempt to substitute any human pain medication. Common over-the-counter human pain relievers are all potentially fatal to cats: ibuprofen causes severe kidney damage, acetaminophen (paracetamol/Tylenol) destroys red blood cells and causes liver failure in cats, and aspirin has a half-life of approximately 40 hours in cats compared to 6 hours in humans, making it extremely easy to overdose. Always seek veterinary care for a cat in pain.

Metacam vs Other Pain Medications for Cats

While Metacam is one of the most commonly prescribed pain medications for cats, it is not the only option. Your veterinarian will choose the most appropriate analgesic based on your cat's specific condition, overall health status, and the type and severity of pain. Here is how Metacam compares to other commonly used feline analgesics.

Buprenorphine is an opioid partial agonist that is widely considered the gold standard for managing moderate to severe acute pain in cats. It can be administered via injection (subcutaneous or intramuscular) or transmucosally (absorbed through the gums). Buprenorphine provides excellent pain relief for 6 to 8 hours per dose and has a good safety profile with relatively few side effects, the most common being mild sedation and dilated pupils. Unlike Metacam, buprenorphine does not carry risks to the kidneys or gastrointestinal tract, making it a safer choice for cats with pre-existing organ disease. However, it requires more frequent dosing and is a controlled substance that must be dispensed by a veterinarian.

Gabapentin is an anticonvulsant drug that has gained significant popularity in feline medicine for managing chronic pain, particularly neuropathic pain and pain associated with osteoarthritis. It works by modulating calcium channels in the nervous system rather than by inhibiting prostaglandin production. Gabapentin has an excellent safety profile in cats and does not affect the kidneys, liver, or GI tract. Its main side effect is sedation, which usually diminishes after a few days of regular dosing. Many veterinarians now use gabapentin in combination with low-dose meloxicam for cats with chronic osteoarthritis, as the two drugs work through different mechanisms and provide synergistic pain relief, potentially allowing a lower dose of each drug to be used.

Robenacoxib (Onsior) is another NSAID that is specifically approved for use in cats in many countries. It is a highly selective COX-2 inhibitor with a short half-life in cats (approximately 1 to 2 hours), which theoretically reduces the risk of accumulation-related toxicity compared to meloxicam's 24-hour half-life. Robenacoxib is approved for up to 3 days of use for acute pain in cats in the US and for longer durations in some other countries. It is available as both an injectable solution and oral tablets.

Solensia (frunevetmab) represents a newer class of pain medication for cats. It is a feline-specific monoclonal antibody that targets nerve growth factor (NGF), a key mediator of osteoarthritic pain. Administered as a once-monthly subcutaneous injection by a veterinarian, Solensia avoids all of the GI and renal risks associated with NSAIDs. It has been approved in the US and EU for the control of pain associated with osteoarthritis in cats and represents a significant advancement in feline pain management, particularly for cats that cannot safely receive NSAIDs.

Frequently Asked Questions